Cancer Diagnostics Startup Identification
|出版日期||內容資訊||英文 430+ Slides
|癌症診斷的Start-Ups企業的特定 Cancer Diagnostics Startup Identification|
|出版日期: 2020年08月20日||內容資訊: 英文 430+ Slides||
What are the startups that have emerged in the cancer diagnostics market? What are they working on? Who are the key people in these companies?
The World Health Organization estimates that cancer was responsible for the death of about 9.6 million people in 2018 making of it a leading cause of death worldwide. A delay in the treatment of cancer can result in a considerable decrease of the patient's chance of survival. Therefore the cancer diagnostics market is booming and highly competitive with a large number of big and small players operating in different market segments. Moreover, a strong need for new diagnostics exists to allow earlier detection with higher sensitivity and higher specificity. New startups are founded every year with the aim of developing the next big diagnostic technology. In this highly diverse and rapidly changing ecosystem, it is crucial to identify new players and monitor their activities to determine opportunities, threats, potential partnerships and collaborations. Because of their small size and technological diversity, these young companies are hard to identify by conventional approaches (web searches, workshops etc.). In this report, Knowmade has thus investigated patents related to cancer diagnostics in order to identify startups through their patent filings. 154 startups having filed their first patent application between 2018-2020 were thus identified, and for 74 of them, the report describes their main activity, products, patents, and key people among their staff. This study reveals that molecular diagnostic is the market that is the more explored by the selected startups, with an emphasis on the applications related to genetic testing. Medical imaging is also a field of interest for several startups identified. Most of which are working on software solutions to improve the interpretation of medical images using artificial intelligence.
Startups have been identified by screening the patent documents published in 2019/2020 claiming technologies related to cancer diagnostics. For each startup identified, the report provides a complete description of its activity and the stage of development of its product. Information about funding rounds and subsidies are also described.
This report includes a detailed description of all the patents filed by identified startups. The elements provided in each overview slide provide essential information to quickly understand the patented technology. For each patent family described, the publication number of Granted/Registered and Pending members are provided, as well as the abstract, the first claim, relevant information about the invention and the most relevant figure (e.g. figure explaining how the invention can be carried out, illustrating its efficacy, etc.).
This report includes a description of the key people and/or inventors involved in each selected startup. Knowing the key people behind a startup helps assessing its chances of success by determining their individual strength and their complementarity. This report is focused on the description of the people who have a technical background. For each key person, the report shows a summary of their educational background, employment history, as well as their other current activities and a link to their LinkedIn profiles.